Alembic Pharmaceuticals Ltd
Abhijit Khot has extensive experience in the field of peptide synthesis and purification, currently serving in research and development at Alembic Pharmaceuticals Limited since November 2022. Prior to this role, Abhijit worked as an Executive at AURO PEPTIDES LIMITED from October 2020 to November 2022, focusing on similar tasks in peptide production. Abhijit's career began at SUN PHARMA as a Senior Officer from November 2018 to October 2020 and included an earlier position at USV PRIVATE LIMITED as an Officer from June 2016 to July 2017. Abhijit Khot holds a Master’s degree in Chemistry from SIA College, Mumbai, obtained in April 2020, and a Bachelor’s degree in Chemistry from Shivaji University, completed in 2016.
Previous companies
This person is not in any teams
This person is not in any offices
Alembic Pharmaceuticals Ltd
9 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.